News and Events

Apr 30, 2019

NCI research team, led by Dr. Mark Schiffman at Division of Cancer Epidemiology and Genetics (DCEG), is conducting a “Cervix Image Sharing Protocol (CISP)” study on artificial intelligence (AI) approach for better and low-cost screening and diagnosis of cervical cancer. TTC executed 14 Data Transfer Agreements (DTAs) with institutions worldwide for the development of algorithms to detect cervical precancers based on cervical images.

Apr 24, 2019

The European medical innovation journal, MedNous, featured a story in its March issue entitled “NCI and Industry: Moving Innovations from the Lab to Patients” authored by Michael Salgaller and Michele Newton. MedNous is both a print and online publication. NCI TTC is highlighted in the both the Letter to the Editor and in the feature story on pages 8 – 9.

Apr 5, 2019
NIH observed rare disease day on 28th February 2019 to build commitment in helping people with rare diseases through research at National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC). NCATS selected eleven honorable mentions and three winners from nearly fifty submissions to a challenge seeking creative ways to raise awareness about rare diseases and the need for expanded research, development of diagnostics and treatments and patient support.
Apr 5, 2019

Tick-borne diseases are emerging as a serious public health problem in the United States. Ticks transmit different infectious diseases including Lyme disease, Rocky Mountain spotted fever and babesiosis. According to CDC, there is more than 30,000 cases of Lyme disease reported each year in the U.S. while the actual incidence of Lyme disease is ten times greater. NIH is developing a strategic plan to accelerate research to develop new diagnostics and therapeutics to address the issue.

Feb 26, 2019
A research team, led by Dennis Drayna, Ph.D., chief of the Section on Genetics of Communication Disorders at the National Institute on Deafness and Other Communication Disorders (NIDCD), conducted detailed genetic analyses on 1,300 adults. A genetic variant found only in people of African descent significantly increases a smoker’s preference for cigarettes containing menthol, a flavor additive. The variant of the MRGPRX4 gene is five to eight times more frequent among smokers who use menthol cigarettes than other smokers.
Jan 29, 2019

The National Cancer Institute (NCI), through the NCI Technology Transfer Center (TTC), now offers a term-limited, exclusive Start-Up Evaluation Option License to start-up companies developing early-stage vaccine, therapeutic, device, and certain diagnostic technologies. The previous Start-up Program offered by the NIH Office of Technology Transfer will apply if companies submitted a license application for a start-up agreement on or before October 15, 2017.

Jan 3, 2019

Proposal(s) are sought in response to RFP # NIH-OD-OLAO-OA-(PLS)-2019 for Patent-Legal Services. This solicitation is full and open to ALL capable business concerns in the U.S. The North American Industry Classification System (NAICS) code for this acquisition is 541110 - Office of Lawyers.

Nov 20, 2018

The NIH’s tech transfer community is pursuing new law firm contracts for managing patent prosecution matters as the current contracts end Spring of 2019. As part of the development for the new Request For Proposals (RFP), the community is providing the public with the chance to comment or ask questions prior to the final RFP posting. A new pre-solicitation notice was recently posted on; the deadline to submit questions and comments is November 30, 2018 10 am Eastern Time.

Sep 18, 2018

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation.  Among them is Michael Redmond, chief of NEI’s Laboratory of Retinal Cell and Molecular Biology.

Sep 18, 2018